High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial

BACKGROUND: Difficult airway management remains a critical procedure with life-threatening adverse events. Current guidelines suggest high-flow therapy by nasal cannulae (HFNC) as a preoxygenation device in this setting. However, there is an evidence gap to support this recommendation. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Vourc'h, Mickael, Huard, Donatien, Le Penndu, Marguerite, Deransy, Romain, Surbled, Marielle, Malidin, Maelle, Mahe, Pierre-Joachim, Guitton, Christophe, Roquilly, Antoine, Malard, Olivier, Feuillet, Fanny, Rozec, Bertrand, Asehnoune, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220226/
https://www.ncbi.nlm.nih.gov/pubmed/37251624
http://dx.doi.org/10.1016/j.eclinm.2023.101998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220226/
https://www.ncbi.nlm.nih.gov/pubmed/37251624
http://dx.doi.org/10.1016/j.eclinm.2023.101998

Ejemplares similares